Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors
Clinical trial NCT00104286 · TERMINATED
Trial details
- NCT number
- NCT00104286
- Sponsor
- SGX Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.